Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub-Saharan Africa.

Item

http://www.wikidata.org/entity/Q38741545

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Impact of HIV Drug Resistance ...... m Costs in Sub-Saharan Africa.

@en

type

Item

label

Impact of HIV Drug Resistance ...... m Costs in Sub-Saharan Africa.

@en

prefLabel

Impact of HIV Drug Resistance ...... m Costs in Sub-Saharan Africa.

@en

P1476

Impact of HIV Drug Resistance ...... m Costs in Sub-Saharan Africa.

@en

P2093

Andrew N Phillips

http://www.w3.org/2001/XMLSchema#string

Fumiyo Nakagawa

http://www.w3.org/2001/XMLSchema#string

John Stover

http://www.w3.org/2001/XMLSchema#string

Meg Doherty

http://www.w3.org/2001/XMLSchema#string

Michael R Jordan

http://www.w3.org/2001/XMLSchema#string

Paul Revill

http://www.w3.org/2001/XMLSchema#string

Silvia Bertagnolio

http://www.w3.org/2001/XMLSchema#string

Valentina Cambiano

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 genetic diversity and transmitted drug resistance mutations among patients from the North, Central and South regions of Angola

What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach.

Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis.

Sharp increase in rates of HIV transmitted drug resistance at antenatal clinics in Botswana demonstrates the need for routine surveillance

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis.

Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling study.

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.

Predicted levels of HIV drug resistance: potential impact of expanding diagnosis, retention, and eligibility criteria for antiretroviral therapy initiation.

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.

P304

1362-1365

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIX089

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

215

http://www.w3.org/2001/XMLSchema#string

P50

Deenan Pillay

P577

2017-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28329236

http://www.w3.org/2001/XMLSchema#string

P921

Sub-Saharan Africa

antiretroviral drug

P932

5451603

http://www.w3.org/2001/XMLSchema#string